Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: David Israel-Rosen who wrote (653)	4/24/1998 3:10:00 PM
From: crysball	Read Replies (2) \| Respond to of 1491

LOTEMAX Market potential Has anyone noticed the projections for laser Opthamology Surgery [vision correcting] are exploding as new procedures are developed which increase the potential [near sighted/far sighted / astigmatism/ & finally correction up to 4.0 Diopters] and concurrently the cost will be coming down {estimate $1,000}, and the time to perform the procedure dramatically diminished {3 seconds for the Holminium Laser of SNRS}. Additionally the safety profile is increased significantly since the Holminium laser does not cut, but simply raises temperature sufficiently to contract the collagen and hence reshape the cornea with a series of very low teperature peripheral tacks. Aren't the estimated 550,000 patients who will receive laser surgery in 1999 candidates for a Lotemax prescription........and consequently the market for Lotemax will benefit from a developing market not factored into the numbers? P.S. the 550,000 number is projected to grow at a nearly exponential rate as the procedures [such as the 'Sands' described above] are approved and 'word of mouth' spreads from satisfied patients....and as the cost comes down.